Joel A Sincavage
Supervisory Patent Examiner (ID: 11124, Phone: (571)272-2610 , Office: P/2910 )
Most Active Art Unit | 2911 |
Art Unit(s) | 2911, 2900, 2901, 2910 |
Total Applications | 4082 |
Issued Applications | 4006 |
Pending Applications | 1 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 575769
[patent_doc_number] => 07456014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => 'Recombinant constructs and their use in reducing gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/476510
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23237
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/456/07456014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476510 | Recombinant constructs and their use in reducing gene expression | Jun 27, 2006 | Issued |
Array
(
[id] => 8629905
[patent_doc_number] => 08361977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Compositions and methods for modulation of SMN2 splicing'
[patent_app_type] => utility
[patent_app_number] => 11/993609
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13414
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11993609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993609 | Compositions and methods for modulation of SMN2 splicing | Jun 22, 2006 | Issued |
Array
(
[id] => 5219275
[patent_doc_number] => 20070160586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Methods for extending the replicative lifespan of cells'
[patent_app_type] => utility
[patent_app_number] => 11/453283
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 20400
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160586.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453283
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453283 | Methods for extending the replicative lifespan of cells | Jun 13, 2006 | Issued |
Array
(
[id] => 5154882
[patent_doc_number] => 20070037765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Formulations comprising antisense nucleotides to connexins'
[patent_app_type] => utility
[patent_app_number] => 11/447599
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10789
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447599 | Formulations comprising antisense nucleotides to connexins | Jun 4, 2006 | Abandoned |
Array
(
[id] => 4469928
[patent_doc_number] => 07943589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'siRNA microbicides for preventing and treating diseases'
[patent_app_type] => utility
[patent_app_number] => 11/916334
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16744
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916334 | siRNA microbicides for preventing and treating diseases | Jun 4, 2006 | Issued |
Array
(
[id] => 5446093
[patent_doc_number] => 20090047319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Pharmaceutical composition for obstructive vascular disease'
[patent_app_type] => utility
[patent_app_number] => 11/921020
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7186
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921020 | Pharmaceutical composition for obstructive vascular disease | May 23, 2006 | Abandoned |
Array
(
[id] => 4740565
[patent_doc_number] => 20080234218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Sirna For Inhibiting Il-6 Expression and Composition Containing Them'
[patent_app_type] => utility
[patent_app_number] => 11/915009
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4278
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915009 | Sirna For Inhibiting Il-6 Expression and Composition Containing Them | May 8, 2006 | Abandoned |
Array
(
[id] => 7977625
[patent_doc_number] => 08071559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Compositions and methods for cancer diagnosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 11/416854
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19017
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416854 | Compositions and methods for cancer diagnosis and treatment | May 1, 2006 | Issued |
Array
(
[id] => 4808139
[patent_doc_number] => 20080171717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Double-Stranded Synthetic Oligonucleotides Useful For Inducing Apoptosis of Osteoclasts For the Treatment of Osteopenic Pathologies'
[patent_app_type] => utility
[patent_app_number] => 11/910086
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4729
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910086 | Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies | Mar 29, 2006 | Issued |
Array
(
[id] => 5754626
[patent_doc_number] => 20060223775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Nucleotide sequence for treating cancer and infection'
[patent_app_type] => utility
[patent_app_number] => 11/386531
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12079
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223775.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386531
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386531 | Nucleotide sequence for treating cancer and infection | Mar 20, 2006 | Abandoned |
Array
(
[id] => 6098075
[patent_doc_number] => 20110003879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/908389
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20404
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003879.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908389
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908389 | Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof | Mar 12, 2006 | Abandoned |
Array
(
[id] => 586349
[patent_doc_number] => 07439059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Compositions and methods for activating genes of interest'
[patent_app_type] => utility
[patent_app_number] => 11/363425
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6759
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439059.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363425
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363425 | Compositions and methods for activating genes of interest | Feb 26, 2006 | Issued |
Array
(
[id] => 5149481
[patent_doc_number] => 20070049541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Method for the modulation of function of transcription factors'
[patent_app_type] => utility
[patent_app_number] => 11/358688
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11358688
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/358688 | Method for the modulation of function of transcription factors | Feb 20, 2006 | Issued |
Array
(
[id] => 4922541
[patent_doc_number] => 20080070857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Pharmaceutical Agents for Preventing Metastasis of Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/884210
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6323
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884210 | Pharmaceutical Agents for Preventing Metastasis of Cancer | Feb 13, 2006 | Abandoned |
Array
(
[id] => 5501591
[patent_doc_number] => 20090162279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm'
[patent_app_type] => utility
[patent_app_number] => 11/914745
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6789
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914745 | Oligonucleotide or its functional homologue, a composition comprising the same and a method of treating B cell neoplasm | Feb 12, 2006 | Issued |
Array
(
[id] => 5479610
[patent_doc_number] => 20090202567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, A COMPOSITION COMPRISING THE SAME AND A METHOD OF TREATING B CELL NEOPLASM'
[patent_app_type] => utility
[patent_app_number] => 11/914744
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6901
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914744
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914744 | OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, A COMPOSITION COMPRISING THE SAME AND A METHOD OF TREATING B CELL NEOPLASM | Feb 12, 2006 | Abandoned |
Array
(
[id] => 5667613
[patent_doc_number] => 20060172963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'RNAi-mediated inhibition of ocular hypertension targets'
[patent_app_type] => utility
[patent_app_number] => 11/344702
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19104
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11344702
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/344702 | RNAi-mediated inhibition of ocular hypertension targets | Jan 31, 2006 | Abandoned |
Array
(
[id] => 5667615
[patent_doc_number] => 20060172965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'RNAi-mediated inhibition of ocular targets'
[patent_app_type] => utility
[patent_app_number] => 11/345361
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19147
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345361
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345361 | RNAi-mediated inhibition of ocular targets | Jan 31, 2006 | Issued |
Array
(
[id] => 5672978
[patent_doc_number] => 20060178333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/346145
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15261
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346145
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346145 | Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof | Jan 31, 2006 | Issued |
Array
(
[id] => 5515561
[patent_doc_number] => 20090215868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension'
[patent_app_type] => utility
[patent_app_number] => 11/794167
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3371
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794167 | Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension | Jan 11, 2006 | Abandoned |